ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04080	Neuroactive ligand-receptor interaction	133/701	423/7206	2.73919901821e-38
ko05033	Nicotine addiction	42/701	56/7206	1.56954778022e-31
ko04724	Glutamatergic synapse	67/701	152/7206	4.21119405714e-29
ko05032	Morphine addiction	46/701	110/7206	3.96536088272e-19
ko04727	GABAergic synapse	45/701	110/7206	2.77266723592e-18
ko04024	cAMP signaling pathway	75/701	279/7206	4.12867247557e-17
ko04713	Circadian entrainment	47/701	136/7206	1.29908947699e-15
ko04723	Retrograde endocannabinoid signaling	54/701	175/7206	2.45797212481e-15
ko04728	Dopaminergic synapse	52/701	185/7206	5.38140449152e-13
ko04725	Cholinergic synapse	47/701	160/7206	1.28112925706e-12
ko04742	Taste transduction	26/701	61/7206	1.40613215692e-11
ko04911	Insulin secretion	37/701	117/7206	3.0982086704e-11
ko04721	Synaptic vesicle cycle	29/701	80/7206	1.09095153691e-10
ko04020	Calcium signaling pathway	60/701	265/7206	2.1704003989e-10
ko04726	Serotonergic synapse	38/701	137/7206	1.20966135454e-09
ko04744	Phototransduction	17/701	36/7206	7.56007687161e-09
ko05030	Cocaine addiction	25/701	73/7206	8.32024372841e-09
ko04921	Oxytocin signaling pathway	48/701	209/7206	8.57590767071e-09
ko05031	Amphetamine addiction	27/701	91/7206	6.78891652592e-08
ko04970	Salivary secretion	26/701	95/7206	6.90115389914e-07
ko05203	Viral carcinogenesis	6/701	277/7206	7.49343104164e-07
ko05014	Amyotrophic lateral sclerosis (ALS)	22/701	74/7206	1.07877558664e-06
ko04972	Pancreatic secretion	28/701	111/7206	1.57519054697e-06
ko04720	Long-term potentiation	26/701	99/7206	1.63506252558e-06
ko04261	Adrenergic signaling in cardiomyocytes	42/701	205/7206	3.19049327392e-06
ko03040	Spliceosome	1/701	145/7206	1.17436998824e-05
ko05164	Influenza A	2/701	167/7206	1.40637871854e-05
ko04514	Cell adhesion molecules (CAMs)	29/701	130/7206	1.56593120014e-05
ko04010	MAPK signaling pathway	55/701	321/7206	2.72561045122e-05
ko04971	Gastric acid secretion	23/701	98/7206	4.67812941685e-05
ko03013	RNA transport	3/701	166/7206	8.71644988095e-05
ko04730	Long-term depression	19/701	78/7206	0.000124279873395
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	19/701	79/7206	0.000149058433599
ko04022	cGMP-PKG signaling pathway	39/701	216/7206	0.0001506046163
ko04060	Cytokine-cytokine receptor interaction	5/701	191/7206	0.000175643894936
ko04740	Olfactory transduction	19/701	80/7206	0.00017807790428
ko05205	Proteoglycans in cancer	10/701	271/7206	0.00022144814355
ko05322	Systemic lupus erythematosus	3/701	151/7206	0.000251773592888
ko04120	Ubiquitin mediated proteolysis	3/701	138/7206	0.000740126779762
ko05169	Epstein-Barr virus infection	7/701	206/7206	0.000750204168188
ko05162	Measles	2/701	120/7206	0.00086638748003
ko04964	Proximal tubule bicarbonate reclamation	9/701	29/7206	0.0012407071286
ko04925	Aldosterone synthesis and secretion	21/701	105/7206	0.00125035507383
ko04141	Protein processing in endoplasmic reticulum	6/701	184/7206	0.00141650851662
ko04924	Renin secretion	18/701	86/7206	0.00145104264211
ko04260	Cardiac muscle contraction	20/701	98/7206	0.00148873075137
ko04976	Bile secretion	17/701	80/7206	0.00174734668272
ko04217	Necroptosis	6/701	178/7206	0.00190394577884
ko04072	Phospholipase D signaling pathway	33/701	197/7206	0.00203691440538
ko04710	Circadian rhythm	11/701	43/7206	0.0021467652553
ko00190	Oxidative phosphorylation	3/701	127/7206	0.00215993852634
ko04621	NOD-like receptor signaling pathway	5/701	157/7206	0.00253368350276
ko04150	mTOR signaling pathway	7/701	184/7206	0.00351620705536
ko04540	Gap junction	23/701	128/7206	0.00366249386373
ko04630	Jak-STAT signaling pathway	4/701	132/7206	0.00464925603526
ko04932	Non-alcoholic fatty liver disease (NAFLD)	7/701	182/7206	0.00485312910061
ko04930	Type II diabetes mellitus	12/701	54/7206	0.00485755927738
ko04961	Endocrine and other factor-regulated calcium reabsorption	13/701	59/7206	0.00604200254121
ko04110	Cell cycle	5/701	145/7206	0.00663221034179
ko05200	Pathways in cancer	31/701	492/7206	0.00717451667329
ko00604	Glycosphingolipid biosynthesis - ganglio series	5/701	14/7206	0.00815012501926
ko05161	Hepatitis B	7/701	173/7206	0.00872949977624
ko05215	Prostate cancer	3/701	111/7206	0.00873042304847
ko05414	Dilated cardiomyopathy	20/701	112/7206	0.00894494335263
ko04146	Peroxisome	2/701	89/7206	0.0108203072838
ko04978	Mineral absorption	9/701	40/7206	0.0128550339155
ko04218	Cellular senescence	8/701	177/7206	0.014282146498
ko04960	Aldosterone-regulated sodium reabsorption	9/701	41/7206	0.0150928011042
ko04145	Phagosome	7/701	162/7206	0.0152576301762
ko03018	RNA degradation	2/701	84/7206	0.0153849051224
ko05218	Melanoma	2/701	85/7206	0.0154587852643
ko04350	TGF-beta signaling pathway	3/701	103/7206	0.0172909386666
ko04360	Axon guidance	34/701	233/7206	0.017511022291
ko05166	HTLV-I infection	17/701	292/7206	0.0200030999207
ko05211	Renal cell carcinoma	3/701	96/7206	0.0231763404554
ko04064	NF-kappa B signaling pathway	3/701	96/7206	0.0231763404554
ko04915	Estrogen signaling pathway	21/701	131/7206	0.023958756527
ko00330	Arginine and proline metabolism	1/701	61/7206	0.0276037394455
ko05168	Herpes simplex infection	9/701	182/7206	0.0300158388888
ko05140	Leishmaniasis	2/701	75/7206	0.0310107774292
ko04711	Circadian rhythm - fly	4/701	13/7206	0.0310952352755
ko05130	Pathogenic Escherichia coli infection	2/701	77/7206	0.031322191819
ko04612	Antigen processing and presentation	2/701	77/7206	0.031322191819
ko04610	Complement and coagulation cascades	2/701	79/7206	0.0325867991553
ko00240	Pyrimidine metabolism	4/701	110/7206	0.0328478212597
ko04510	Focal adhesion	14/701	240/7206	0.0353192029556
ko04142	Lysosome	7/701	151/7206	0.0358141946825
ko05410	Hypertrophic cardiomyopathy (HCM)	16/701	100/7206	0.0405444502516
ko04750	Inflammatory mediator regulation of TRP channels	19/701	122/7206	0.042895517301
ko05133	Pertussis	3/701	87/7206	0.0443620734803